ArticleBMC cardiovascular disorders2025
Prevalence and clustering trends association of modifiable cardiovascular disease risk factors and ASCVD risk change in ethnic areas of the Southwest China plateau: progressively increasing sex disparity.
Article in BMC cardiovascular disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe purpose of the study was to determine the prevalence and clustering changes of cardiovascular disease (CVD) risk factors, the atherosclerotic cardiovascular diseases (ASCVD) risk change in ethnic minority areas of the Southwest China Plateau from the perspective of sex disparity.
methodsThis study conducted two cross-sectional studies in Yunnan Province, China, in 2018 and 2024, respectively, enrolling 1,197 and 1,047 participants aged 35–75 years with no history of CVD. The China-PAR model was used to assess participants’ 10-year risk of ASCVD. Changes in the prevalence and clustering of 9 CVD risk factors were described. Multivariate-adjusted Poisson regression by robust was used to calculate the association between the number of CVD risk factors and high risk of ASCVD.
resultsCompared with 2018, the age-standardized prevalence of modifiable metabolic CVD risk factors such as hypertension (22.4% to 41.7%), central obesity (24.2% to 39.1%), and overweight and obesity (11.2% to 15.1%) has risen rapidly; the increase among males was much higher than among females, while the age-standardized prevalence of modifiable behavioral CVD risk factors has declined. There was no significant change in the clustering number of CVD risk factors, but there was a significant change in the combination of CVD risk factors, particularly a significant increase associated with hypertension. The proportion of individuals classified as being at high risk for ASCVD also increased significantly (6.7% vs 10.6%). For each CVD risk factor, the high risk of ASCVD increased by 5%, with a higher risk among males and 55–75 years.
conclusionFrom 2018 to 2024, modifiable metabolic CVD risk factors increased substantially in high-altitude ethnic minority regions of Southwest China. Comprehensive lifestyle interventions should be implemented in the future to promote the prevention and control of ASCVD risk and gradually reduce sex disparity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.